Monoclonal antibodies against antithrombin β

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9908942
SERIAL NO

14770222

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This patent document relates to antibodies, antigen-binding antibody fragments (Fabs), and other protein scaffolds, directed against human antithrombin β complexed with heparin and/or heparin-like structure (ATβH). These ATβH binding proteins can block the anti-coagulant activity of ATβ to induce coagulation. Therapeutic uses of these antibodies and binders are described herein as are methods of panning and screening specific antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BAYER HEALTHCARE LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dittmer, Frank Duesseldorf, DE 21 64
Gritzan, Uwe Colgone, DE 21 85
Hermiston, Terry Mill Valley, US 52 270
Jin, Ye San Ramon, US 47 423
Murphy, John E Boston, US 38 342
Myles, Timothy Sunnyvale, US 8 3
Strerath, Michael Duesseldorf, DE 16 95

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 6, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 6, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00